Flatt Stephen Fowler 4
4 · NATIONAL HEALTHCARE CORP · Filed Mar 3, 2026
Research Summary
AI-generated summary of this filing
NHC CEO Stephen Flatt Receives Restricted Share Award
What Happened
- Stephen Fowler Flatt, CEO and director of National Healthcare Corp (NHC), was granted 3,090 restricted shares on 2026-02-27. The award was issued at $0.00 per share (no cash paid).
Key Details
- Transaction date: 2026-02-27; Filing date: 2026-03-03 (filed within the required Form 4 window).
- Shares granted/acquired: 3,090 restricted shares; Price paid: $0.00; Total cash outlay: $0.
- Shares owned after transaction: Not reported in the provided filing.
- Footnote: The shares vest in three equal installments — 33 1/3% on 2027-01-01, 33 1/3% on 2028-01-01, and 33 1/3% on 2029-01-01.
- No 10b5-1 plan, tax-withholding sale, or immediate sale noted in this filing.
Context
- These are restricted stock awards, not open‑market purchases or sales. They typically serve as compensation and vest over time, so they do not represent an immediate change in market exposure or realized proceeds. The economic value will depend on NHC’s future share price as the grant vests.
Insider Transaction Report
Form 4
Flatt Stephen Fowler
DirectorCEO
Transactions
- Award
Common Stock
[F1]2026-02-27+3,090→ 62,237 total
Holdings
- 6,147
Option to Purchase Common Stock
Exercise: $53.94From: 2024-03-08Exp: 2028-03-08→ Common Stock (6,147 underlying) - 10,000
Option to Purchase Common Stock
Exercise: $94.10From: 2025-03-05Exp: 2029-03-05→ Common Stock (10,000 underlying) - 18,000
Option to Purchase Common Stock
Exercise: $90.62From: 2026-02-28Exp: 2030-02-28→ Common Stock (18,000 underlying) - 20,000
Option to Purchase Common Stock
Exercise: $157.13From: 2027-02-23Exp: 2031-02-23→ Common Stock (20,000 underlying)
Footnotes (1)
- [F1]Grant of restricted shares that are subject to a three-year vesting schedule with the first 33 1/3% vesting on 1/1/2027, the next 33 1/3% vesting on 1/1/2028, and the final 33 1/3% vesting on 1/1/2029.
Signature
/s/ Stephen Flatt|2026-03-03